Financial Times - July 7

July 7 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.


- GSK investor support for spin-off vindicates rejection of Unilever bid, says chief Link

- BA to cut another 10,300 flights escalating airline disruption Link

- HSBC closes in on deal to sell Russian business to Expobank Link

- AO World plans £40mn capital raise after sharp share price fall Link


- GlaxoSmithKline's GSK.L chief executive, Emma Walmsley, on Wednesday said a shareholder vote in favour of co's consumer healthcare business spin-off had vindicated it's decision to turn down a takeover bid from Unilever ULVR.L .

- British Airways, owned by IAG ICAG.L , on Wednesday said it will cancel 10,300 more short-haul flights up to the end of October, pointing to disruptions at airports over the summer holidays.

- HSBC HSBA.L is in advanced talks to sell its Russian corporate lending business to Expobank, as many major banks exit the country.

- British online electricals retailer AO World AO.L said on Wednesday it intends to raise about 40 million pounds ($47.69 million) through a placing and a primarybid offer. ($1 = 0.8387 pounds) (Compiled by Bengaluru newsroom)

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.